ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,483Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1107

$2.23M Total Retail Price of All Prescriptions

Rank: 4 out of 1107

966 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 966 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 966 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 24,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 1,206 785 1 2
OMEPRAZOLE 1,096 637 2 4
FUROSEMIDE 1,084 822 3 7
SIMVASTATIN 895 680 4 5
LEVOTHYROXINE SODIUM 857 583 5 3
AMLODIPINE BESYLATE 780 488 6 6
ATENOLOL 717 516 7 19
WARFARIN SODIUM 699 493 8 15
POTASSIUM CHLORIDE 649 513 9 14
METOPROLOL TARTRATE 625 407 10 10
METFORMIN HCL 621 358 11 8
CLOPIDOGREL 602 399 12 28
NEXIUM 601 321 13 18
CRESTOR 570 277 14 23
RANITIDINE HCL 566 378 15 21
HYDROCHLOROTHIAZIDE 536 384 16 11
PANTOPRAZOLE SODIUM 533 358 17 30
ISOSORBIDE MONONITRATE ER 504 416 18 34
PREDNISONE 497 348 19 40
TAMSULOSIN HCL 401 309 20 30
METOPROLOL SUCCINATE 396 267 21 16
GABAPENTIN 385 264 22 9
PLAVIX 364 236 23 39
SERTRALINE HCL 355 203 24 20
ATORVASTATIN CALCIUM 305 181 25 13
RAMIPRIL 294 176 26 84
LANTUS 285 188 27 49
LEVOFLOXACIN 276 183 28 71
DICLOFENAC SODIUM 269 153 29 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 266 135 30 24
FLUOXETINE HCL 265 116 31 47
PRAVASTATIN SODIUM 264 169 32 12
CLONIDINE HCL 264 192 32 53
HYDROCODONE-ACETAMINOPHEN 256 208 S3 34 1
HYDROXYZINE PAMOATE 256 116 R 34 152
TRAZODONE HCL 248 145 36 33
PAROXETINE HCL 237 149 37 45
ADVAIR DISKUS 235 195 38 54
PROAIR HFA 235 123 38 37
CEPHALEXIN 226 137 40 81
GLIMEPIRIDE 211 127 41 43
DONEPEZIL HCL 211 197 41 32
INSULIN SYRINGE 206 91 43 78
CARVEDILOL 201 139 44 27
FLUTICASONE PROPIONATE 201 123 44 38
DIGOXIN 201 172 44 52
LYRICA 199 143 47 83
PROMETHAZINE HCL 198 88 R 48 44
CYMBALTA 197 104 49 50
LOSARTAN POTASSIUM 191 118 50 29
SPIRIVA 189 143 51 57
AMITRIPTYLINE HCL 188 151 R 52 48
IBUPROFEN 188 79 52 63
MIRTAZAPINE 184 134 54 61
TRICOR 181 105 55 95
NAMENDA 178 144 56 42
POLYETHYLENE GLYCOL 3350 177 142 57 46
EXELON 175 141 58 103
LOVAZA 170 92 59 101
TRIAMCINOLONE ACETONIDE 169 120 60 137
CITALOPRAM HBR 168 77 61 17
SPIRONOLACTONE 162 84 62 72
SUCRALFATE 160 108 63 121
THEOPHYLLINE ANHYDROUS 154 89 64 158
METOCLOPRAMIDE HCL 153 55 65 116
MELOXICAM 148 103 66 25
TIZANIDINE HCL 145 53 67 73
AVODART 144 109 68 204
SINGULAIR 143 107 69 65
LACTULOSE 137 96 70 89
LANTUS SOLOSTAR 135 79 71 129
BUMETANIDE 132 92 72 123
KLOR-CON M20 132 89 72 75
RISPERIDONE 131 100 74 79
NAPROXEN 130 68 75 80
ALLOPURINOL 127 77 76 36
METHYLPREDNISOLONE 127 73 76 119
DILTIAZEM 24HR ER 124 65 78 172
CEFDINIR 123 83 79 163
FLUCONAZOLE 121 66 80 150
DILTIAZEM 24HR CD 119 85 81 126
HYDRALAZINE HCL 119 74 81 99
AZITHROMYCIN 118 71 83 35
PEN NEEDLE 118 60 83 192
NYSTATIN 114 78 85 110
IRBESARTAN 112 84 86 276
GEMFIBROZIL 111 41 87 107
DOXYCYCLINE HYCLATE 111 55 87 128
VERAPAMIL ER 109 96 89 113
LEVETIRACETAM 108 25 90 141
FINASTERIDE 108 85 90 130
BUSPIRONE HCL 106 66 92 107
JANUVIA 104 85 93 60
NOVOLOG 104 77 93 127
GLIPIZIDE 102 81 95 64
CELEBREX 100 82 96 85
METOLAZONE 99 46 97 217
TERAZOSIN HCL 99 67 97 173
VENLAFAXINE HCL ER 98 53 99 117
LOVASTATIN 97 68 100 55
COLCRYS 96 67 101 233
LANSOPRAZOLE 96 78 101 102
CILOSTAZOL 95 52 103 194
METHOCARBAMOL 94 55 R 104 142
MECLIZINE HCL 91 74 105 114
ULTRA COMFORT 91 65 10 105 359
PRADAXA 90 75 107 241
PHENYTOIN SODIUM EXTENDED 90 28 107 147
HUMALOG 90 63 107 226
TRIAMTERENE-HCTZ 89 67 110 62
AMOXICILLIN 88 68 111 90
COMBIVENT 87 58 112 112
AVAPRO 87 66 112 404
DIOVAN HCT 87 67 112 106
ENALAPRIL MALEATE 86 78 115 98
LOSARTAN-HYDROCHLOROTHIAZIDE 85 64 116 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 63 117 88
DILTIAZEM ER 84 73 117 139
DOXAZOSIN MESYLATE 83 74 119 92
GLYBURIDE-METFORMIN HCL 83 69 R 119 165
DIVALPROEX SODIUM 83 52 119 96
DICLOFENAC POTASSIUM 81 52 122 363
CIPROFLOXACIN HCL 80 54 123 59
DIOVAN 80 40 123 51
CYCLOBENZAPRINE HCL 79 21 R 125 56
NITROSTAT 79 38 125 188
MONTELUKAST SODIUM 78 53 127 118
APIDRA 78 50 10 127 410
LIPITOR 76 65 129 109
VENTOLIN HFA 76 47 129 97
AMLODIPINE BESYLATE-BENAZEPRIL 75 71 131 77
QUETIAPINE FUMARATE 73 71 132 94
ALENDRONATE SODIUM 72 72 133 41
ONGLYZA 72 61 133 205
ROPINIROLE HCL 71 24 135 69
SULINDAC 70 47 136 224
SOTALOL 70 69 136 222
BUPROPION XL 68 45 138 200
SYNTHROID 67 50 139 70
DETROL LA 65 48 140 223
LEVOCETIRIZINE DIHYDROCHLORIDE 63 33 141 203
BUPROPION HCL SR 63 25 141 190
FAMOTIDINE 60 60 143 111
TRAMADOL HCL 60 57 143 26
RANEXA 60 49 143 272
EVISTA 60 59 143 135
INDOMETHACIN 60 26 R 143 313
TOPIRAMATE 58 0 148 160
VESICARE 58 35 148 228
ULORIC 54 41 150 321
TRILIPIX 53 18 151 153
SYMBICORT 52 36 152 124
PREMARIN 52 24 R 152 149
PROPRANOLOL HCL 51 38 154 134
SEROQUEL 51 48 154 182
PATADAY 51 45 154 319
ESCITALOPRAM OXALATE 50 32 157 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.